Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IVA compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name
IVA
Inventiva S.A.
Change
Mkt cap
Revenue
Revenue
IRD
Opus Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
IVA
Inventiva S.A.
vs
IRD
Opus Genetics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IVA: latest quarter not drawable. IRD: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IVA, solid
IRD, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IVA
2
—
Pharmaceutical Research Associates
unlisted
supplier
—
Chia Tai Tianqing Pharmaceutical
unlisted
customer
Shared
0
No shared counterparties.
Only IRD
4
VTRS
Viatris
supplier
—
FDA Office of Orphan Drug Products
unlisted
supplier
—
Foundation Fighting Blindness
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
National Institutes of Health
unlisted
supplier
IVA
Inventiva S.A.
Change
3.66
▼
−1.88%
· post 3.66
Mkt cap
$705.3M
Revenue
—
Revenue
—
IRD
Opus Genetics, Inc.
Change
3.67
▲
+0.44%
· post 3.64
Closed
Oct 30 '26
Mkt cap
$305.3M
Revenue
$755,000
Q2 FY26
Revenue
$14M
FY25
vs
Compare
Closed
Oct 30 '26
IVA
Inventiva S.A.
vs
IRD
Opus Genetics, Inc.
3.66
▼
−1.88%
post 3.66
Price
3.67
▲
+0.44%
post 3.64
$705.3M
Mkt cap
$305.3M
—
Revenue
$755,000
Q2 FY26
—
Revenue
$14M
FY25
Change
Change
IVA
3.66
▼
−1.88%
vs
IRD
3.67
▲
+0.44%
Closed
Oct 30 '26